Drug discovery informatics and development is an extremely complex process that involves generation of large volumes of data. At present the market for drug discovery informatics is largely unmet.

The global castrate-resistant prostate cancer market is estimated to be valued at US$ 9.5 Bn in 2023, and is expected to exhibit a CAGR of 8.2% over the forecast period (2023-2030).

“Coherent Market Insights offers Up to 45% discount on Medical Ceramics Market Reports on Single User Access and Unlimited User Access“